PDUFA VII to expand FDA’s real-time oncology reviews to supplements for all therapeutic areas
The FDA’s popular program to speed up its reviews of new oncology drugs and supplemental applications by months will be expanded into a larger program …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
